The antiviral effects of baloxavir marboxil against influenza A virus infection in ferrets
Open Access
- 13 June 2020
- journal article
- research article
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 14 (6) , 710-719
Abstract
Background Baloxavir marboxil (BXM), the oral prodrug of baloxavir acid (BXA), greatly reduces virus titers as well as influenza symptoms of uncomplicated influenza in patients. Objectives To investigate the pharmacokinetic profiles of BXA and its efficacy against influenza A virus infection in ferrets. Methods Ferrets were dosed orally with BXM (10 and 30 mg/kg twice daily for 1 day), oseltamivir phosphate (OSP) (5 mg/kg twice daily for 2 days) or vehicle to measure the antiviral effects of BXM and OSP. The pharmacokinetic parameters of BXA was determined after single oral dosing of BXM. Results The maximum plasma concentrations of BXA were observed at 1.50 and 2.00 hours with the two BXM doses, which then declined with an elimination half‐life of 6.91 and 4.44 hours, respectively. BXM at both doses remained detectable in the plasma in ferrets, which may be due to higher stability in liver microsomes. BXM (10 and 30 mg/kg twice daily) treatment at Day 1 post‐infection (p.i.) reduced virus titers by ≥3 log10 of the 50% tissue culture infective doses by Day 2, which was significantly different compared with vehicle or OSP. Body temperature drops over time were significantly greater with BXM than with vehicle or OSP. Significant reduction in virus titers was also demonstrated when BXM was administrated after symptom onset at Day 2 p.i. compared with vehicle and OSP, although body temperature changes largely overlapped between Day 2 and Day 4. Conclusions The results highlight the rapid antiviral action of BXM with post‐exposure prophylaxis or therapeutic dosing in ferrets and offer support for further research on prevention of influenza virus infection and transmission.Keywords
Funding Information
- Shionogi & Co., Ltd., Osaka, Japan
This publication has 40 references indexed in Scilit:
- Prolonged Influenza Virus Shedding and Emergence of Antiviral Resistance in Immunocompromised Patients and FerretsPLOS Pathogens, 2013
- Structural and Biochemical Basis for Development of Influenza Virus Inhibitors Targeting the PA EndonucleasePLOS Pathogens, 2012
- Airborne Transmission of Influenza A/H5N1 Virus Between FerretsScience, 2012
- Species Differences in Tissue Distribution and Enzyme Activities of Arylacetamide Deacetylase in Human, Rat, and MouseDrug Metabolism and Disposition, 2012
- Efficacy of Single Intravenous Injection of Peramivir against Influenza B Virus Infection in Ferrets and Cynomolgus MacaquesAntimicrobial Agents and Chemotherapy, 2011
- The ferret as a model organism to study influenza A virus infectionDisease Models & Mechanisms, 2011
- Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferretsAntiviral Research, 2011
- Pathogenesis and Transmission of Swine-Origin 2009 A(H1N1) Influenza Virus in FerretsScience, 2009
- The genomic and epidemiological dynamics of human influenza A virusNature, 2008
- The Ferret: An Animal Model to Study Influenza VirusLab Animal, 2004